Accueil   Diary - News   All news VALBIOTIS confirms its interest in the study of the intestinal microbiota

VALBIOTIS confirms its interest in the study of the intestinal microbiota

  • VALBIOTIS develops leading expertise in this field of research
  • VALBIOTIS compiles a base of human data in the field of metabolic diseases, with high value potential
  • VALBIOTIS focuses on the French population’s understanding of the intestinal microbiota through an exclusive Opinéa survey

 

La Rochelle, 17 October 2018 (17:35 CEST) – VALBIOTIS (ALVAL/PEA/SME eligible), a French Research & Development company committed to scientific innovation for preventing and combating metabolic diseases, confirms its interest in the study of the intestinal microbiota, a promising field of investigation on innovative solutions for metabolic diseases.

 

Read the press release

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree